Home > Insider Trading > Filing (0001209191-22-021151)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Therapeutics Public Ltd Co	HZNP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611468	W. Paul Hoelscher	C/O Horizon Therapeutics Plc, 70 St. Stephen?S Green Dublin L2 D02 E2X4	Evp, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2022-03-07	66,626	$0.00	1,049	No	4	G	Direct
Ordinary Shares	Acquisiton	2022-03-07	66,626	$0.00	245,015	No	4	G	Indirect	By Trust
Ordinary Shares	Disposition	2022-03-07	172,226	$0.00	72,789	No	4	G	Indirect	By Trust
Ordinary Shares	Acquisiton	2022-03-07	172,226	$0.00	172,226	No	4	G	Indirect	By LLC
Ordinary Shares	Acquisiton	2022-03-23	26,090	$15.96	27,139	No	4	M	Direct
Ordinary Shares	Disposition	2022-03-23	26,090	$110.00	1,049	No	4	S	Direct
Ordinary Shares	Disposition	2022-03-23	11,699	$110.01	160,527	No	4	S	Indirect	By LLC
Ordinary Shares	Disposition	2022-03-24	1,481	$110.00	159,046	No	4	S	Indirect	By LLC
Ordinary Shares	Disposition	2022-03-25	663	$110.00	158,383	No	4	S	Indirect	By LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	G	Indirect	By Trust
No	4	G	Indirect	By Trust
No	4	G	Indirect	By LLC
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By LLC
No	4	S	Indirect	By LLC
No	4	S	Indirect	By LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2022-03-23	26,090	$0.00	26,090	$15.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,275		2024-06-26	No	4	M	Direct

Footnotes

These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.115 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021.
The option is fully vested and exercisable.